Vanity is good. Vanity is right. Vanity works. It clarifies, cuts through, and captures the essence of human progress. From art to science, from money to love, the pursuit of beauty has marked the upward surge of humanity.
Medical aesthetics is the latest expression of that surge. Not indulgence, not excess–but possibility. Injectopedia exists to frame it with evidence and elegance. Heddy brings it to life in practice.
If you’ve ever felt the pull between where you are and where you know you could be, this is your bridge. Injectopedia isn’t just a resource–it’s a revolution. And darling, you’re already part of it.
Q: Can I mix a collagen stimulator and HA in the same syringe?
Patient: Mid-40s female. Bellafill (hyperdiluted 4:1 with lido + epi) injected into forehead with 25G 2″ cannula for volume loss August 2019. Within a week, developed inflammation and lumps/bumps–no infection.
Initial treatment was 7 day oral prednisone, resolved inflammation, but lumps/bumps remained. Follow-ups included intralesional Kenalog, 5-FU, and saline, resulting in partial resolution, but led to steroid atrophy and resistance.
5+ yrs later, nodules remain at rest and with expression.
How would you approach this?
👉 Click an option to vote (we’ll tally and share in the next issue).
May 2019
Aug 2019
June 2023
Got a tricky case worth sharing?
Injectopedia is built on collective wisdom – submit yours for a future feature and help the whole community level up.
3.85 years /
790 syringes
That’s the average climb from novice to competent injector,
per Cotofona et al. 2024.
Expert status?
Double those numbers.
(Yes, TikTok nurse that means you’re still a rookie.)
Waldencast (owner of Milk Makeup + Obagi) just acquired Novaestiq Corp. and exclusive U.S. rights to Saypha injectables–EU-developed HA gels pending FDA approval–slated to launch under Obagi medical.
They’re paying ~$3M upfront and performance-based earn-outs tied to FDA nods and $100-$200 sales goals. Transit: they expect to grab a slice of the $2B U.S. filler market, doubling their addressable aesthetic spend by 2029.
Their ambition? Make Obagi to fillers what Clinique is to skincare. Consumers ask for Botox. Soon, they’ll ask for Obagi Injectables.
Why it matters?
Source: Beauty Independent, PR Newswire, Stock Titan
👉 Click an option to tell us your favorite.
